@article{3afe41c90a7a47158c328cea7d7eb524,
title = "Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy",
abstract = "Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen.",
keywords = "Colectomy, Infliximab, Ulcerative colitis, Colectomy, Infliximab, Ulcerative colitis",
author = "Alessandro Armuzzi and Antonio Gasbarrini and Luisa Guidi and Rita Monterubbianesi and Annalisa Aratari and Marco Daperno and Livia Biancone and Maria Cappello and Vito Annese and Gabriele Riegler and Ambrogio Orlando and Angelo Viscido and Gianmichele Meucci and Alessandro Lavagna and Raffaello Sostegni and Sara Onali and Claudio Papi and Anna Kohn",
year = "2014",
doi = "10.1016/j.crohns.2014.01.006",
language = "English",
volume = "8",
pages = "852--858",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "NETHERLANDS: ELSEVIER SCIENCE",
}